- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DEXA sales pace Hologic revenues
Bone densitometry firm Hologic enjoyed a strong fiscal 1996 thanksto higher sales of its Acclaim series of dual-energy x-ray bonedensitometers. The Waltham, MA, company's acquisition of miniC-arm manufacturer FluoroScan Imaging Systems also contributedto
Bone densitometry firm Hologic enjoyed a strong fiscal 1996 thanksto higher sales of its Acclaim series of dual-energy x-ray bonedensitometers. The Waltham, MA, company's acquisition of miniC-arm manufacturer FluoroScan Imaging Systems also contributedto Hologic's revenue growth.
For the year (end-September), Hologic posted revenues of $91.6million, up 62% compared with sales of $56.5 million in fiscal1995. The company's net income for the year stood at $11.4 million,compared with $3.3 million the year before, when a legal battlewith Lunar squeezed Hologic's profits.
For the fourth quarter, Hologic had revenues of $24.4 million,up 46% compared with sales of $16.7 million in the fourth quarterof 1995. The company's net income was $2.1 million, compared with$988,000 in the same period a year ago.
While the FluoroScan acquisition added over $3 million in salesto Hologic's fourth quarter, most of the company's growth camethrough sales in the bone densitometry segment: Hologic's revenuein the period would have grown 64% without the FluoroScan acquisition.Sales of Acclaim systems reached record levels in the U.S. dueto new drugs for treating osteoporosis, according to Hologic chairmanand CEO David Ellenbogen.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
